Eidos Therapeutics Inc
(EIDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | SRRK | IMVT | ||
| Company | Eidos Therapeutics Inc | Scholar Rock Holding Corp | Immunovant Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 45.77 | 26.88 | ||
| High | 128.49 | 48.00 | 27.34 | ||
| Low | 116.83 | 44.73 | 24.85 | ||
| Latest | 122.21 | 47.62 | 27.05 | ||
| Change | -6.23 | +3.17 | +2.99 | ||
| % Change | -4.85% | +7.13% | +12.43% | ||
| Volume | 335,500 | 1,201,300 | 3,313,300 | ||
| 20-Day Average Volume | 113,985 | 1,045,950 | 1,514,865 | ||
| Previous Close | 128.44 | 44.45 | 24.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 45.21 | 26.10 | ||
| 20-Day Raw Stochastic | 36.63% | 76.07% | 80.77% | ||
| 20-Day Relative Strength | 56.42 | 56.67 | 56.28 | ||
| Weighted Alpha | +136.62 | +36.36 | +41.62 | ||
| Today's Opinion | 88% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +7.40% since 01/30/26 | +4.04% since 01/30/26 | ||
| Low | 116.83 on 01/25/21 | 43.67 on 02/02/26 | 23.90 on 02/05/26 | ||
| High | 131.08 on 01/20/21 | 49.82 on 02/03/26 | 27.34 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +15.27% since 01/06/26 | +4.44% since 01/06/26 | ||
| Low | 116.24 on 01/05/21 | 40.63 on 01/12/26 | 23.90 on 02/05/26 | ||
| High | 132.54 on 01/04/21 | 49.82 on 02/03/26 | 27.80 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +65.35% since 11/06/25 | +14.28% since 11/06/25 | ||
| Low | 69.38 on 10/30/20 | 27.07 on 11/07/25 | 21.43 on 11/10/25 | ||
| High | 132.54 on 01/04/21 | 49.82 on 02/03/26 | 27.80 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +37.57% since 08/06/25 | +69.49% since 08/06/25 | ||
| Low | 38.44 on 07/31/20 | 27.07 on 11/07/25 | 14.32 on 08/11/25 | ||
| High | 132.54 on 01/04/21 | 49.82 on 02/03/26 | 27.80 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,857,574 | 4,741,243 | ||
| Shares Outstanding, K | 38,873 | 102,007 | 175,277 | ||
| Annual Sales | 26,690,000 | 0 | 0 | ||
| Annual Net Income | -37,840,000 | -246,290,000 | -413,840,000 | ||
| Last Quarter Sales | 130,000 | 0 | 0 | ||
| Last Quarter Net Income | -30,180,000 | -102,220,000 | -126,500,000 | ||
| 60-Month Beta | -0.16 | 0.67 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.90 on 11/14/25 | -0.61 on 02/06/26 | ||
| Latest Earnings Date | 02/24/21 | 02/26/26 | 02/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||